Ipsen Biopharmaceuticals Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Ipsen Biopharmaceuticals Inc (Ipsen), a subsidiary of Ipsen SA, is a biotechnology company that develops and commercializes pharmaceuticals in the areas of neurology and endocrinology. The company’s product portfolio includes Increlex (mecasermin) injection indicated for the treatment of children suffering from short stature due to severe primary IGFD; Onivyde injection indicated for the treatment of patients with metastatic adenocarcinoma of the pancreas; Somatuline Depot (lanreotide) injection used to treat acromegaly and neuroendocrine tumors; and Dysport (abobotulinumtoxinA) injection indicated for the treatment of adults with cervical dystonia, upper limb spasticity, and pediatric patients with lower limb spasticity. The company partners with biopharmaceutical companies, scientific and clinical communities to develop new therapies against endocrine and metabolic diseases. Ipsen is headquartered in Basking Ridge, New Jersey, the US.

Ipsen Biopharmaceuticals Inc Key Recent Developments

Feb 14,2019: Ipsen delivers strong 2018 results and expects continued sales and profit growth in 2019
Apr 26,2018: Ipsen Reports Strong First Quarter 2018 Sales Growth of 23.1% at Constant Exchange Rates
Feb 21,2018: Arix Bioscience and Ipsen sign a strategic agreement to develop and commercialise innovative therapies
Jan 10,2018: Ipsen appoints Aidan Murphy as Executive Vice-President, Technical Operations

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.